Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104194A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003104192A2 Controlled release formulation of lamotrigine
12/18/2003WO2003104191A1 Novel trans - lutein enriched xanthophyll ester concentrate anda process for its preparation
12/18/2003WO2003104188A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/18/2003WO2003104187A1 Amidoacetonitrile compounds and their use as pesticides
12/18/2003WO2003104184A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
12/18/2003WO2003104181A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103822A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
12/18/2003WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
12/18/2003WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103717A1 Therapeutic conjugate consisting of a mek inhibitor and a targeting agent
12/18/2003WO2003103714A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
12/18/2003WO2003103713A1 Rapidly disintegrating tablet and process for producing the same
12/18/2003WO2003103712A1 Combinations comprising epothilones and pharmaceutical uses thereof
12/18/2003WO2003103711A1 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents
12/18/2003WO2003103709A2 Modulation of bone development
12/18/2003WO2003103708A1 BIOFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/18/2003WO2003103701A1 Compositions and methods for treating diabetes
12/18/2003WO2003103699A1 Use of ramoplanin to treat diseases associated with the use of antibiotics
12/18/2003WO2003103696A1 Cardiac glycosides for treating muscle pain and spasm
12/18/2003WO2003103694A1 Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis
12/18/2003WO2003103691A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103685A1 A method of treating human skin and a skin care composition for use in such a method
12/18/2003WO2003103684A1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
12/18/2003WO2003103683A1 Use of estetrol and analogues for treating or preventing cardiovascular pathologies, in particular atherosclerosis
12/18/2003WO2003103682A1 Compositions for cancer therapy saponins or sapogenins
12/18/2003WO2003103681A2 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema
12/18/2003WO2003103679A1 Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
12/18/2003WO2003103678A1 Oxaziridine precursors and derivatives in the treatment of epithelial cancer tumors
12/18/2003WO2003103676A2 Method of treating cancer using kinase inhibitors
12/18/2003WO2003103675A2 Combination treatments for purinoceptor-related disorders
12/18/2003WO2003103674A1 Tablets comprising ciprofloxacin hydrochloride
12/18/2003WO2003103673A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
12/18/2003WO2003103672A1 Sequential therapy comprising a 20(s)-camptothecin and an anthracycline
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103670A1 Novel uses of dl-thp
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103667A1 Inhibitors against complex ii of electron transport system
12/18/2003WO2003103665A1 Antiallergic
12/18/2003WO2003103664A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003WO2003103659A1 Therapeutic agent for overactive bladder
12/18/2003WO2003103658A1 Immunity-related protein kinase inhibitors
12/18/2003WO2003103657A1 Remedies for neurodegenerative diseases
12/18/2003WO2003103655A1 Therapeutic agent for cancer
12/18/2003WO2003103654A1 NF-kappaB ACTIVATION INHIBITORS
12/18/2003WO2003103653A1 Methods of treating alzheimer's disease using aryl alkanoic acid amides
12/18/2003WO2003103652A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING AROMATICALLY SUBSTITUTED omega-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003WO2003103649A1 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
12/18/2003WO2003103648A1 Therapeutic drug for diabetes
12/18/2003WO2003103647A1 Inhibitors against the activation of ap-1 and nfat
12/18/2003WO2003103644A2 Guanidino phenylalanin compounds used as urokinase inhibitors
12/18/2003WO2003103643A1 Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor
12/18/2003WO2003103641A1 Patch
12/18/2003WO2003103640A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
12/18/2003WO2003103637A2 Modified release, multiple unit drug delivery systems
12/18/2003WO2003103635A1 Extended release formulation of divalproex sodium
12/18/2003WO2003103634A1 Sustained release oral dosage forms of gabapentin
12/18/2003WO2003103633A1 Nanoparticulate sterol formulations and sterol combinations
12/18/2003WO2003103632A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
12/18/2003WO2003103631A1 Novel high viscosity embolizing compositions comprising prepolymers
12/18/2003WO2003103623A1 Cosmetic or dermatological formulation for skincare after or before sunbathing or shaving
12/18/2003WO2003103614A2 Method and compositions for the treatment of edematous-firbrsclerotic panniculopathy
12/18/2003WO2003103613A2 Induction of insulin expression
12/18/2003WO2003103612A2 Method of using prostacyclin to treat respiratory syncytial virus infections
12/18/2003WO2003103610A2 Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003WO2003103598A2 Amidine derivatives for treating amyloidosis
12/18/2003WO2003103596A2 Stabilized nanoparticle formulations of camptotheca derivatives
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103588A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
12/18/2003WO2003103586A2 Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids
12/18/2003WO2003103584A2 Ether substituted imidazopyridines
12/18/2003WO2003103583A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003WO2003103580A2 Combinations for the treatment of rheumatoid arthritis
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003103569A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
12/18/2003WO2003103568A2 Use of an agent inducing dopachrome tautomerase (trp-2) expression as protecting agent for hair follicle melanocytes and uses thereof
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
1 ... 5237 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 5249 5250 5251 5252 5253 5254 5255 5256 5257 ... 7860